PPD

SEPTEMBER 6, 2023

Approaches to outsourcing clinical trials have changed significantly in recent years. Mixing of service models — a strategy that drug developers are leveraging now more than ever — can bring life-changing therapies to market faster. Often working directly within client’s systems and SOPs.

Drug Development 98

Drug Development Clinical Trials Drugs Clinical Research 98

The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Enrolling study subjects, setting up patient randomization and managing drug supply are critical to the success of a clinical trial. .

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Drug Target Review

SEPTEMBER 10, 2024

The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. In recent years, the biopharmaceutical industry has identified rapid Toxicology (Tox) material supply as the new critical path to IND readiness.

Drug Development 64

Drug Development Clinical Supply Production Protein Expression 64

The Premier Consulting Blog

OCTOBER 26, 2022

Early development and first-in-human In the early stages of drug development, process and chemistry, manufacturing, and controls (CMC) knowledge may be limited.

Production 40

Production Assay Development Clinical Supply Engineering 40

LifeSciVC

AUGUST 21, 2024

Drug development is a long process, and patients are waiting. I am fortunate to have a great Tech Ops team at Lifordi who is on top of managing all the moving parts across the globe for making tox and clinical supply for us. Don’t get me wrong. I know we all haven’t exactly been coasting this summer.

Clinical Trials 62

Clinical Trials Trials Disease Treatment 62

The Pharma Data

OCTOBER 27, 2020

The collaboration aims to leverage Molecular Partners’ proprietary DARPin® technologies and Novartis’ broad expertise in global drug development, regulatory affairs, manufacturing and commercialization to rapidly advance the program in keeping with the unprecedented global urgency created by the pandemic.

Therapies 52

Therapies Virus Treatment Clinical Trials 52